BPC-157

BPC-157 5MG

Manufacturer: Unique Pharma
Package: 5 mg/vial
Common Names: BPC-157, Body Protection Compound-157, Pentadecapeptide BPC-157

Info: BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids and derived from a sequence associated with human gastric juice. It has attracted significant interest in experimental research because of its reported biological activity across pathways involved in tissue response, cellular signaling, vascular function, and gastrointestinal physiology. 

Tissue Repair Research: BPC-157 has been investigated in preclinical models for its potential influence on processes associated with tissue regeneration, cellular response, angiogenesis, and wound-healing mechanisms. These findings have made the peptide a subject of ongoing experimental research.

Gastrointestinal Research: BPC-157 has been studied in relation to gastrointestinal integrity and protective mechanisms involving the stomach and intestinal tract. Experimental research has examined its interaction with pathways associated with mucosal protection and tissue response.

Dosage Range and Duration of Use

BPC-157 5 mg (5 mg/vial): Each vial contains 5 mg of BPC-157 in lyophilized form. BPC-157 remains an investigational peptide and does not have an officially established or approved dosing regimen for routine clinical use. In research protocols and experimental studies, standard dosing typically ranges from 200 mcg to 500 mcg per day (often administered as 250 mcg once or twice daily via subcutaneous injection near the target area or orally, depending on the research objective).

Dosage duration in experimental settings commonly spans 2 to 6 weeks, aligned with specific recovery or healing timelines. The quantity of 5 mg per vial refers solely to the total amount of peptide contained in the product and should not be interpreted as a recommended single individual dose or treatment schedule.

Side Effects

Because BPC-157 has not been established as an approved therapeutic treatment, its complete safety profile in humans has not been determined. Potential reactions may depend on the route of administration, exposure, individual characteristics, and other substances used concurrently.

Post-Cycle Therapy

BPC-157 is not an anabolic steroid, androgenic compound, or testosterone-suppressing anabolic agent. It therefore does not require conventional post-cycle therapy (PCT) protocols associated with anabolic steroid use. As an investigational peptide, however, its use and discontinuation should be considered within an appropriate medical or research framework.

Storage:

Store lyophilized BPC-157 according to the manufacturer's storage specifications and protect the vial from excessive heat, moisture, and direct exposure to light. After reconstitution, storage requirements and stability may depend on the diluent, concentration, preparation method, and manufacturer's instructions.